Invetech announces its first educational seminar at the upcoming BioProcess International Analytical and Quality Summit 2008, 2-4 June, Hyatt Regency, Cambridge, MA
As leaders in delivery of integrated platforms and process designs in the pharmaceutical and biotechnology industries, Invetech will present a methodology used to assess the technical and commercial drivers that resulted in the automation of a single patient therapeutic processing system.
"Our business is to translate client processes developed by the scientific community into robust systems for successful commercialisation.
"We believe conference delegates will benefit from our experience in characterizing Cellular Therapeutic Process automation" said presenter Ian Fitzpatrick, manager of manufacturing innovation, Invetech.
"Delegates will be able to relate our practical examples to their own developments in this area.
"They will learn critical quality and batch record management are central to automation activity.
"In addition we will show how novel process steps can confidently be addressed with purpose designed devices and equipment by the application of the "quality by design methodology", says Fitzpatrick.
The presentation, 'Determining design requirements for tailored automated autologous vaccine production to achieve marketable costs' includes a case study, which discusses the process of evaluating and selecting novel unit processes that resulted in the use of single-use devices.
Invetech will demonstrate the opportunities this technology creates while addressing clinical process needs and affordability.
This includes the development of totally-closed processing systems incorporating novel process features and single-use disposables.
Design requirements and examples of design solutions will provide a practical view for those interested in addressing process risk and achieving reimbursable costs.
